Chronic systemic inflammation predicts long-term mortality among patients with fatty liver disease: Data from the National Health and Nutrition Examination Survey 2007–2018
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0312877 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Xinghe Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China. Hauptthemen laut MEDLINE: Inflammation, Nutrition Surveys. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liaoning Provincial Science and Technology Plan project, henyang Science and Technology Plan Project, the Graduate Student Science and Technology Innovation Fund of Shenyang Medical College.
Abstract (Originalsprache)
Background
Low-grade systemic inflammation (SI) in patients with fatty liver disease (FLD) is an important hallmark of disease onset and progression. This study aims to evaluate the prognostic significance of novel SI markers in FLD.
Methods
This was a retrospective cohort study. We included adult patients with FLD with complete data and analyzed the association between chronic SI and long-term mortality in patients with FLD. Systemic immune-inflammation index (SII), pan-immune-inflammation value (PIV), and systemic inflammation response index (SIRI) were evaluated based on peripheral blood counts and FLD was determined by the Fatty Liver Index.
Results
A total of 5497 patients with FLD were included in the final analysis. SII and PIV (but not SIRI) were found to be associated with all-cause and cardiovascular mortality in univariate analysis. Multivariate Cox regression analysis and KM analysis demonstrated that SII and PIV were associated with all-cause mortality, with SII showing a nonlinear correlation in RCS. PIV (but not SII) was associated with the cardiovascular-related survival probability over time. Stratified analysis indicated that the positive correlation between SII and PIV and all-cause mortality was not altered by subgroups.
Conclusions
SII and PIV are strongly and consistently associated with all-cause mortality in patients with FLD, with PIV potentially showing a closer association with cardiovascular mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China.
- Department of Clinical Laboratory Center, Xinjiang Medical University Affiliated Tumor Hospital, Urumqi, China.
- School of Basic Medical Sciences, Shenyang Medical College, Shenyang, China.
ORCID-Profile: Hongpeng Guo
Förderung
- Liaoning Provincial Science and Technology Plan project
- henyang Science and Technology Plan Project
- the Graduate Student Science and Technology Innovation Fund of Shenyang Medical College
- Shenyang Health Commission Scientific Research Project
Zitieren
APA
Pan, X., Lv, J., Liu, M., Li, Y., Zhang, Y., Zhang, R., Liu, J., Sun, C., & Guo, H. (2024). Chronic systemic inflammation predicts long-term mortality among patients with fatty liver disease: Data from the National Health and Nutrition Examination Survey 2007–2018. PLOS ONE. https://doi.org/10.1371/journal.pone.0312877
Vancouver
Pan X, Lv J, Liu M, Li Y, Zhang Y, Zhang R, et al. Chronic systemic inflammation predicts long-term mortality among patients with fatty liver disease: Data from the National Health and Nutrition Examination Survey 2007–2018. PLOS ONE. 2024. doi:10.1371/journal.pone.0312877
BibTeX
@article{Pan2024,
author = {Pan, Xinghe and Lv, Jie and Liu, Man and Li, You and Zhang, Yitong and Zhang, Rui and Liu, Junliang and Sun, Chenglin and Guo, Hongpeng},
title = {Chronic systemic inflammation predicts long-term mortality among patients with fatty liver disease: Data from the National Health and Nutrition Examination Survey 2007–2018},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0312877}
}
EUVIMED